Fundraising FoxMedical Devices Startups
7,118 companies tagged Medical Devices, with their investors and founders.
Aerska develops RNA interference (RNAi) medicines designed for targeted delivery across the blood-brain barrier to treat, delay, and prevent central nervous system and neurological diseases. The company combines next-generation RNA therapeutics, brain delivery technologies, and biomarker-guided precision medicine to silence disease-causing genes in the brain.
10 investors
Alentis is a biotech company developing therapies for chronic liver disease, fibrosis, and cancer based on the molecular biology of liver disease. It operates as a clinical-stage biopharmaceutical company advancing small molecules, antibodies, and related drug programs in oncology and fibrotic diseases.
10 investors
Apheris provides a platform enabling large global life sciences organizations to collaborate on sensitive, proprietary data and jointly train machine learning models on distributed datasets while maintaining privacy across teams, borders, and organizations.
10 investors
Arda develops therapeutics using single-cell computational biology to target and eliminate pathogenic cells in chronic diseases. The company combines drug development expertise with cellular biology to create new therapeutic approaches.
10 investors
ArriVent BioPharma is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing medicines for difficult-to-treat diseases, starting with cancers. Its pipeline centers on its lead candidate firmonertinib (formerly furmonertinib) and novel oncology therapeutics such as next-generation antibody drug conjugates.
10 investors
AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions. The company was founded in 2025 following a strategic combination of atai Life Sciences and Beckley Psytech.
10 investors
Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets. The company combines genomics data analysis with therapeutic design to create more targeted treatments for cancer patients.
10 investors
Dimension Bio is a biotechnology company developing regenerative therapeutics using its BioNidum platform, which combines materials science, 3D printing, and digital manufacturing to produce implantable and injectable biosynthetic scaffolds that promote tissue healing. Its products target clinical markets such as sports medicine, orthopedics, plastic and reconstructive surgery, aesthetics, dental, and neuro/spine, as well as cell delivery applications for conditions like liver failure and Type 1 diabetes.
10 investors
Dren Bio is a clinical-stage biopharmaceutical company developing novel antibody therapeutics designed to selectively eliminate pathogenic cells and disease-causing agents, with a pipeline targeting oncology, autoimmune diseases, immunology, and neurology.
10 investors
Earli develops a biotechnology platform that uses genetic constructs to detect cancer and produce therapeutic proteins by reprogramming cancer cells. The company focuses on oncology diagnostics and therapeutics for cancer patients.
10 investors
EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair. The company translates tissue engineering research into therapeutic products for orthopedic and surgical applications.
10 investors
Flywheel provides a platform for organizing, managing, and sharing medical imaging data. The company serves pharmaceutical companies, medical device manufacturers, AI developers, and academic medical centers to accelerate clinical trials, advance AI development, and streamline research workflows.
10 investors
Heartbeat Health builds a modern cardiology ecosystem to deliver cardiovascular care through technology-enabled interventions. The company serves healthcare providers and patients seeking advanced cardiac care solutions.
10 investors
Heartflow provides an AI-based analysis that converts a coronary CTA scan into a personalized 3D model of the heart, assessing anatomy and physiology to help diagnose and manage coronary artery disease (CAD). Its platform, Heartflow One, is used by cardiologists and clinicians to guide diagnosis and treatment decisions for patients.
10 investors
Infiuss Health operates a decentralized clinical research platform that connects pharmaceutical sponsors with patient participants, physicians, and hospitals to conduct remote or hybrid clinical trials. The platform aims to accelerate drug development by diversifying participant cohorts and streamlining the recruitment and management of clinical studies.
10 investors
Kopra Bio develops cancer immunotherapy technology that converts cancer cells into biofactories to produce their own destruction. The company operates in the biotech and cancer treatment space.
10 investors
Moons provides invisible, removable dental aligners for teeth straightening in Mexico. The company delivers personalized treatment plans with 3D smile visualization, orthodontist follow-up, and aligner sets at prices starting from 27,990 MXN.
10 investors
Natera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions. The company serves patients, physicians, and healthcare systems across oncology, women's health, and organ health.
10 investors
NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications. The company translates bioelectronic devices from preclinical research toward first-in-human studies and commercialization.
10 investors
Notable Labs operates an automated laboratory that tests combinations of existing drugs against individual patients' blood cancer cells to identify effective treatment options for patients whose cancers have become resistant to standard therapies.
10 investors
Osmind is a public benefit corporation developing technology and research infrastructure to accelerate evidence-based mental health treatments, including therapies like ketamine, and to improve patient access to care.
10 investors
OtoNexus Medical Technologies is developing an ultrasound-based otoscope (Novoscope) that uses a miniaturized sensor in a single-use ear speculum tip to give clinicians objective, point-of-care data on middle-ear fluid and infection type. The device targets pediatric otitis media diagnosis to support antibiotic stewardship and reduce misdiagnosis for physicians, hospitals, and payers.
10 investors
Outpace Bio develops engineered protein technologies and cell therapies to treat solid tumors, focusing on protein design and T cell engineering to improve cancer treatment efficacy and safety.
10 investors
RayzeBio develops radiopharmaceutical therapies for cancer treatment. The company is a subsidiary of Bristol Myers Squibb focused on advancing targeted cancer therapies to patients.
10 investors